0 CHECKOUT

PRODUCT FILTERS

REGION

18
4
3
3
3

COUNTRY

PRICE

36
51
105
145

PUBLISHED

3
31
58
145

PRODUCT TYPE

131
8
4
2

Lymphoma Drugs

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

T-Cell Lymphomas-Pipeline Insights, 2016

“ T-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the T-Cell Lymphomas. The report covers the product profiles in...

Published:  March 2016
Price:  From

Indolent Lymphoma-Pipeline Insights, 2016

“ Indolent Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Indolent Lymphoma. The report covers the product profiles...

Published:  March 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

“ Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Anaplastic Large Cell Lymphoma (ALCL)....

Published:  March 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

“ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Peripheral T-Cell Lymphomas (PTCL). The report...

Published:  March 2016
Price:  From

Lymphoblastic Lymphoma-Pipeline Insights, 2016

“ Lymphoblastic Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. The report covers the product...

Published:  March 2016
Price:  From

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

“ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. The report covers the...

Published:  March 2016
Price:  From

Mycosis Fungoides-Pipeline Insights, 2016

“ Mycosis Fungoides-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Mycosis Fungoides. The report covers the product profiles...

Published:  March 2016
Price:  From

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

“ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The report covers the product...

Published:  March 2016
Price:  From

B-Cell Lymphomas-Pipeline Insights, 2016

“ B-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Lymphomas. The report covers the product profiles in...

Published:  March 2016
Price:  From

Waldenstrom Macroglobulinemia-Pipeline Insights, 2016

“ Waldenstrom Macroglobulinemia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Waldenstrom Macroglobulinemia. The report covers...

Published:  March 2016
Price:  From

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Lymphoma...

Published:  March 2016
Price:  From

Mycosis Fungoides-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mycosis Fungoides-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  March 2016
Price:  From

Velcade -Drug Insights, 2016

Our report, “Velcade- Drug Insights, 2016” highlights the Velcade marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  January 2016
Price:  From

Targretin Capsules -Drug Insights, 2016

Our report, “Targretin Capsules- Drug Insights, 2016” highlights the Targretin Capsules marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients